Search

Conozca las preguntas que debe hacerle a un médico especialista en cáncer pulmonar después de recibir el diagnóstico, de la mano de un especialista de MSK que ha tratado con éxito a muchas personas con cáncer pulmonar.

… Friday, November 1, 2024 Si le han diagnosticado cáncer pulmonar, es importante a dónde acudir en primer lugar. También es importante saber qué preguntas hacerle a su equipo de atención médica. En las últimas dos décadas se han logrado avances notables en la comprensión y el tratamiento del cáncer pulmonar

The first-ever clinical trial of a new kind of drug, called pirtobrutinib or LOXO-305, has shown promising results in a phase I/II study.

… Friday, March 5, 2021 Summary Pirtobrutinib (also known as LOXO-305), a type of drug called a BTK inhibitor, appears to be effective in many people with blood cancers called B cell malignancies. The incidence of severe side effects for the drug is also very low. The first-ever clinical trial of a new

A new study sheds light on a little understood biological process called quiescence, which enables blood-forming stem cells to exist in a dormant or inactive state in which they are not growing or dividing. According to the study's findings, researchers identified the genetic pathway used to maintain a cell's quiescence, a state that allows bone marrow cells to escape the lethal effects of standard cancer treatments.

… Friday, January 9, 2009 A new study sheds light on a little understood biological process called quiescence, which enables blood-forming stem cells to exist in a dormant or inactive state in which they are not growing or dividing. According to the study’s findings, researchers identified the genetic

The combination of nivolumab (Opdivo®) and ipilimumab (Yervoy®) has shown improved progression-free survival (PFS) compared with chemotherapy as a first-line treatment for people with a high tumor mutational burden (TMB) in advanced non-small cell lung cancer (NSCLC). Data from the CheckMate -227 trial is being reported by Matthew Hellmann, MD, of Memorial Sloan Kettering Cancer Center, at the AACR Annual Meeting 2018. This research is featured in the meeting’s press program, and findings are being presented in the Clinical Trials Plenary Session, “Immunotherapy Combinations: The New Frontier in Lung Cancer.”

… Monday, April 16, 2018 The combination of nivolumab (Opdivo ® ) and ipilimumab (Yervoy ® ) has shown improved progression-free survival (PFS) compared with chemotherapy as a first-line treatment for people with a high tumor mutational burden (TMB) in advanced non-small cell lung cancer (NSCLC). Data

New research funds have been awarded by the RSNA Research & Education Foundation to Robert Young, MD for Using Functional MRI and Diffusion Tensor Imaging of the Language Pathway to Optimize Brain Tumor Resection.

… Monday, June 13, 2011 New research funds have been awarded by the RSNA Research & Education Foundation to Robert Young, MD for  Using Functional MRI and Diffusion Tensor Imaging of the Language Pathway to Optimize Brain Tumor Resection .

Learn how MSK physician-scientist Christopher Klebanoff is working to bring immunotherapy to more patients, especially those with solid tumors.

… Wednesday, December 20, 2023 When Christopher Klebanoff, MD , came to Memorial Sloan Kettering Cancer Center (MSK) from the National Cancer Institute in 2016, he was focused on a singular goal: bringing the promise of cellular immunotherapies to the more than 80% of cancers that as yet lack an effective

Discover the significance of the Josie Robertson Surgery Center’s signature art piece.

… Thursday, January 26, 2017 VIDEO | 03:27 Wordfall Take a closer look at Wordfall, which was created in memory of a gifted young poet, Brendan Ogg. Video Details Summary Visitors to Memorial Sloan Kettering’s Josie Robertson Surgery Center — which opened one year ago — will first notice the cascading

Learn how MSK nurse practitioner Mindy Jaffe guides children and young adults with cancer and their families through their reproductive options.

… Monday, January 15, 2018 Learning that cancer treatments can affect a child’s fertility can make already difficult conversations even harder. Mindy Jaffe at MSK makes those discussions go a bit smoother. As a nurse practitioner in MSK’s Cancer and Fertility Program , Ms. Jaffe counsels young patients

Get to know Ashley Chui, a chemical biology graduate student in the Sloan Kettering Institute.

… Monday, March 23, 2020 Summary As part of Women’s History Month, we are profiling some of MSK’s star female graduate students and postdoctoral fellows training to be leaders in their fields. Ashley Chui is a graduate student in the Bachovchin lab  in the Sloan Kettering Institute. When and how did you

Joan Argetsinger Steitz, PhD, Sterling Professor of Molecular Biophysics and Biochemistry at Yale School of Medicine, will also be honored with the 2021 Honorary Degree and the MSK Medal for Outstanding Contributions to Biomedical Research.

… Wednesday, May 19, 2021 VIDEO | MSK Tassel Turn 2021 MSK Tassel Turn 2021 Video Details During a virtual commencement ceremony on Wednesday, May 19, 2021, at 3:00 p.m. et, Memorial Sloan Kettering Cancer Center (MSK) will recognize seven Gerstner Sloan Kettering (GSK) 2021 graduates and honor Joan Argetsinger